Update on Preclinical Development and Clinical Translation of Cholecystokinin-2 Receptor Targeting Radiopharmaceuticals

The cholecystokinin-2 receptor (CCK2R) has been a target of interest for molecular imaging and targeted radionuclide therapy for two decades. However, so far CCK2R targeted imaging and therapy has not been introduced in clinical practice. Within this review the recent radiopharmaceutical development...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Elisabeth von Guggenberg, Petra Kolenc, Christof Rottenburger, Renata Mikołajczak, Alicja Hubalewska-Dydejczyk
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/39929c74eb0f41469615cdf0f02b4031
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares